New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)
This grant funds the development of innovative glucose control technologies that utilize artificial intelligence and machine learning tools and strategies.
About this program
The New Generation of Glucose Control Technologies grant aims to support research and development in the field of glucose management, particularly through the integration of advanced AI and ML methodologies. This initiative is designed for researchers and organizations focused on improving diabetes care and management through technological advancements. By fostering innovation in glucose control, the grant seeks to enhance patient outcomes and provide more effective solutions for individuals living with diabetes. Eligible applicants include academic institutions, research organizations, and private companies that are working on cutting-edge technologies in glucose monitoring and control. The grant encourages collaboration between various stakeholders in the healthcare and technology sectors to drive forward-thinking solutions. Projects funded by this grant should demonstrate a clear application of AI/ML tools in their approach to glucose management, ensuring that the outcomes are both practical and impactful.
Eligibility
Academic institutions, research organizations, and private companies focused on glucose management technologies.